Cancer Statistics, 2009, CA: A Cancer Journal for Clinicians, vol.59, issue.4, pp.225-274, 2009. ,
DOI : 10.3322/caac.20006
Current Status of Adjuvant Therapy for Pancreatic Cancer, The Oncologist, vol.15, issue.11, pp.1205-132010, 2010. ,
DOI : 10.1634/theoncologist.2010-0121
Replicating viruses as selective cancer therapeutics, Molecular Medicine Today, vol.2, issue.12, pp.519-546, 1996. ,
DOI : 10.1016/S1357-4310(97)81456-6
Autonomous parvovirus vectors, Viral Vectors: Basic Science and Gene Therapy, pp.97-118, 2000. ,
Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV, Clinical Cancer Research, vol.15, issue.2, pp.511-520, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1088
URL : https://hal.archives-ouvertes.fr/pasteur-00748222
Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent, Cancer Biology & Therapy, vol.10, issue.12, pp.1280-1289, 2011. ,
DOI : 10.4161/cbt.10.12.13455
Interferons as potential adjuvants in prophylactic vaccines, Expert Opinion on Biological Therapy, vol.160, issue.3, pp.1489-500, 2010. ,
DOI : 10.1182/blood-2008-11-190520
Clinical Use of Interferon-??, Annals of the New York Academy of Sciences, vol.3, issue.1, pp.69-79, 2009. ,
DOI : 10.1111/j.1749-6632.2009.05069.x
Interferon-?? reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages, International Journal of Cancer, vol.21, issue.2, pp.367-73, 2009. ,
DOI : 10.1002/ijc.24401
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial, Br J Cancer, vol.82, pp.1138-4410735496, 2000. ,
Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma Cells, Pancreas, vol.5, issue.3, pp.267-77, 1990. ,
DOI : 10.1097/00006676-199005000-00005
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer, Cancer Letters, vol.268, issue.1, pp.98-109, 2008. ,
DOI : 10.1016/j.canlet.2008.03.056
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans, Science, vol.331, issue.6024, pp.1612-1618, 2011. ,
DOI : 10.1126/science.1198443
Reovirus inhibits the peritoneal dissemination of pancreatic cancer cells in an immunocompetent animal model, Oncology Reports, vol.21, issue.6, pp.1381-1385, 2009. ,
DOI : 10.3892/or_00000364
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide, Clinical Cancer Research, vol.15, issue.8, pp.2777-88, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2342